NEW YORK (GenomeWeb News) – Lentigen has signed a contract with the US Army that extends a 2006 agreement that uses the company’s lentiviral vector technology for biodefense, the company said today.
The Army will use the lentiviral technology, which is used to deliver genes or gene silencing sequences into cells, at its Edgewood Chemical Biological Center.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.